nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—DRD4—conduct disorder	0.905	1	CbGaD
Rotigotine—DRD5—Dopamine receptors—DRD4—conduct disorder	0.00959	0.1	CbGpPWpGaD
Rotigotine—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00637	0.0667	CbGpPWpGaD
Rotigotine—DRD3—Dopamine receptors—DRD4—conduct disorder	0.00629	0.0658	CbGpPWpGaD
Rotigotine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00481	0.0504	CbGpPWpGaD
Rotigotine—DRD5—Monoamine GPCRs—DRD4—conduct disorder	0.00212	0.0222	CbGpPWpGaD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00199	0.0209	CbGpPWpGaD
Rotigotine—DRD5—Amine ligand-binding receptors—DRD4—conduct disorder	0.00178	0.0186	CbGpPWpGaD
Rotigotine—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00177	0.0186	CbGpPWpGaD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00153	0.016	CbGpPWpGaD
Rotigotine—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00144	0.0151	CbGpPWpGaD
Rotigotine—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.00141	0.0147	CbGpPWpGaD
Rotigotine—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.00139	0.0145	CbGpPWpGaD
Rotigotine—DRD5—Monoamine GPCRs—HTR2A—conduct disorder	0.00138	0.0145	CbGpPWpGaD
Rotigotine—DRD5—G alpha (s) signalling events—CGA—conduct disorder	0.00131	0.0137	CbGpPWpGaD
Rotigotine—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.00125	0.0131	CbGpPWpGaD
Rotigotine—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00121	0.0127	CbGpPWpGaD
Rotigotine—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00118	0.0124	CbGpPWpGaD
Rotigotine—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.00117	0.0122	CbGpPWpGaD
Rotigotine—DRD5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00116	0.0122	CbGpPWpGaD
Rotigotine—CYP1A2—Methylation—COMT—conduct disorder	0.0011	0.0115	CbGpPWpGaD
Rotigotine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00109	0.0114	CbGpPWpGaD
Rotigotine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00106	0.0111	CbGpPWpGaD
Rotigotine—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.00105	0.011	CbGpPWpGaD
Rotigotine—DRD4—Monoamine GPCRs—HTR2A—conduct disorder	0.00102	0.0107	CbGpPWpGaD
Rotigotine—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00102	0.0107	CbGpPWpGaD
Rotigotine—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.000918	0.00962	CbGpPWpGaD
Rotigotine—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.000906	0.00949	CbGpPWpGaD
Rotigotine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.000893	0.00935	CbGpPWpGaD
Rotigotine—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.000872	0.00913	CbGpPWpGaD
Rotigotine—DRD4—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000858	0.00898	CbGpPWpGaD
Rotigotine—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.000818	0.00857	CbGpPWpGaD
Rotigotine—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00079	0.00827	CbGpPWpGaD
Rotigotine—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000772	0.00808	CbGpPWpGaD
Rotigotine—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000762	0.00798	CbGpPWpGaD
Rotigotine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000693	0.00726	CbGpPWpGaD
Rotigotine—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000688	0.0072	CbGpPWpGaD
Rotigotine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000688	0.0072	CbGpPWpGaD
Rotigotine—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000664	0.00695	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000626	0.00655	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Other—DRD4—conduct disorder	0.000617	0.00646	CbGpPWpGaD
Rotigotine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000583	0.0061	CbGpPWpGaD
Rotigotine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00055	0.00576	CbGpPWpGaD
Rotigotine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000531	0.00556	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—CGA—conduct disorder	0.000476	0.00499	CbGpPWpGaD
Rotigotine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000466	0.00488	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000462	0.00483	CbGpPWpGaD
Rotigotine—DRD4—GPCRs, Other—HTR2A—conduct disorder	0.000453	0.00474	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000416	0.00435	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00041	0.00429	CbGpPWpGaD
Rotigotine—DRD5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000409	0.00428	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.000403	0.00421	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—SLC6A4—conduct disorder	0.000392	0.0041	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000372	0.00389	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00037	0.00388	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000357	0.00374	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000353	0.00369	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—CGA—conduct disorder	0.000352	0.00368	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00035	0.00367	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.000348	0.00364	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000332	0.00347	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.000327	0.00343	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000316	0.00331	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000314	0.00329	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—CGA—conduct disorder	0.000312	0.00327	CbGpPWpGaD
Rotigotine—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.000289	0.00302	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.000282	0.00295	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00028	0.00293	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000272	0.00285	CbGpPWpGaD
Rotigotine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000272	0.00284	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—CGA—conduct disorder	0.000269	0.00282	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000268	0.00281	CbGpPWpGaD
Rotigotine—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000267	0.00279	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—DRD4—conduct disorder	0.000267	0.00279	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000266	0.00279	CbGpPWpGaD
Rotigotine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.000261	0.00273	CbGpPWpGaD
Rotigotine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000252	0.00264	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00025	0.00262	CbGpPWpGaD
Rotigotine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000249	0.00261	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—CGA—conduct disorder	0.000244	0.00256	CbGpPWpGaD
Rotigotine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000242	0.00253	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000239	0.0025	CbGpPWpGaD
Rotigotine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000234	0.00245	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000233	0.00244	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00023	0.0024	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000229	0.00239	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000228	0.00239	CbGpPWpGaD
Rotigotine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000221	0.00231	CbGpPWpGaD
Rotigotine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000211	0.00221	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000207	0.00217	CbGpPWpGaD
Rotigotine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000205	0.00215	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0002	0.0021	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—CGA—conduct disorder	0.000199	0.00208	CbGpPWpGaD
Rotigotine—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000197	0.00206	CbGpPWpGaD
Rotigotine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000193	0.00202	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CGA—conduct disorder	0.00018	0.00189	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000179	0.00187	CbGpPWpGaD
Rotigotine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000177	0.00186	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000177	0.00186	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000176	0.00185	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000176	0.00184	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000175	0.00183	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000175	0.00183	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—HTR2A—conduct disorder	0.000174	0.00182	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000169	0.00177	CbGpPWpGaD
Rotigotine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000163	0.00171	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000162	0.0017	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CGA—conduct disorder	0.00016	0.00168	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000159	0.00167	CbGpPWpGaD
Rotigotine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000158	0.00165	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000158	0.00165	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.00161	CbGpPWpGaD
Rotigotine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000152	0.0016	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000152	0.0016	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000152	0.00159	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.000151	0.00158	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00015	0.00157	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000145	0.00151	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CGA—conduct disorder	0.000144	0.00151	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.00014	0.00146	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000139	0.00146	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000139	0.00146	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD4—conduct disorder	0.000137	0.00143	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000135	0.00142	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000135	0.00141	CbGpPWpGaD
Rotigotine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000134	0.0014	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000134	0.0014	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000133	0.0014	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000132	0.00139	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000132	0.00138	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000131	0.00137	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	0.000128	0.00134	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—EP300—conduct disorder	0.000127	0.00133	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000123	0.00128	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000121	0.00126	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—WASF1—conduct disorder	0.000116	0.00121	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.000116	0.00121	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000115	0.0012	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000115	0.0012	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.000114	0.00119	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.000113	0.00118	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000113	0.00118	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000112	0.00117	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000111	0.00117	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CGA—conduct disorder	0.000107	0.00112	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000103	0.00108	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.0001	0.00105	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	9.94e-05	0.00104	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	9.88e-05	0.00103	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	9.84e-05	0.00103	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.61e-05	0.00101	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CGA—conduct disorder	9.59e-05	0.001	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CGA—conduct disorder	9.47e-05	0.000991	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—DRD4—conduct disorder	9.1e-05	0.000952	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—DRD4—conduct disorder	8.97e-05	0.00094	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	8.93e-05	0.000935	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	8.92e-05	0.000934	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	8.73e-05	0.000914	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—COMT—conduct disorder	8.72e-05	0.000913	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—MAOA—conduct disorder	8.66e-05	0.000907	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—EP300—conduct disorder	8.66e-05	0.000906	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	8.61e-05	0.000902	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	8.6e-05	0.0009	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CGA—conduct disorder	8.55e-05	0.000895	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—WASF1—conduct disorder	8.54e-05	0.000894	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CGA—conduct disorder	8.25e-05	0.000864	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	8.1e-05	0.000848	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD4—conduct disorder	8.09e-05	0.000847	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	7.82e-05	0.000819	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—WASF1—conduct disorder	7.69e-05	0.000805	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—WASF1—conduct disorder	7.59e-05	0.000794	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	7.56e-05	0.000792	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	7.26e-05	0.00076	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CGA—conduct disorder	7.24e-05	0.000758	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—DRD4—conduct disorder	6.87e-05	0.000719	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	6.85e-05	0.000717	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—WASF1—conduct disorder	6.61e-05	0.000692	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	6.59e-05	0.00069	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	6.54e-05	0.000684	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	6.45e-05	0.000675	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	5.93e-05	0.000621	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	5.86e-05	0.000613	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	5.82e-05	0.000609	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—WASF1—conduct disorder	5.81e-05	0.000608	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	5.62e-05	0.000588	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD4—conduct disorder	5.37e-05	0.000563	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD4—conduct disorder	5.3e-05	0.000555	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	5.29e-05	0.000553	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HTR2A—conduct disorder	5.28e-05	0.000552	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	5.1e-05	0.000534	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CGA—conduct disorder	5.05e-05	0.000529	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	4.93e-05	0.000517	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—EP300—conduct disorder	4.88e-05	0.000511	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	4.79e-05	0.000501	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD4—conduct disorder	4.62e-05	0.000484	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	4.48e-05	0.000469	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CGA—conduct disorder	4.28e-05	0.000448	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—DRD4—conduct disorder	4.06e-05	0.000425	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HTR2A—conduct disorder	3.89e-05	0.000408	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HTR2A—conduct disorder	3.51e-05	0.000367	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HTR2A—conduct disorder	3.46e-05	0.000362	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CGA—conduct disorder	3.3e-05	0.000346	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	3.12e-05	0.000327	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	3.01e-05	0.000316	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EP300—conduct disorder	2.8e-05	0.000293	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.65e-05	0.000277	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—COMT—conduct disorder	2.28e-05	0.000239	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MAOA—conduct disorder	2.27e-05	0.000237	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—conduct disorder	2.06e-05	0.000216	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—COMT—conduct disorder	1.93e-05	0.000202	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MAOA—conduct disorder	1.92e-05	0.000201	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.86e-05	0.000195	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—conduct disorder	1.86e-05	0.000194	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—conduct disorder	1.83e-05	0.000192	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.65e-05	0.000173	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000167	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—COMT—conduct disorder	1.49e-05	0.000156	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MAOA—conduct disorder	1.48e-05	0.000155	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—conduct disorder	1.4e-05	0.000147	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—conduct disorder	9.78e-06	0.000102	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—conduct disorder	8.29e-06	8.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—conduct disorder	6.4e-06	6.7e-05	CbGpPWpGaD
